Breast Cancer Epidemiology in Blacks and Whites: Disparities in Incidence, Mortality, Survival Rates and Histology

Baquet, Claudia R.; Mishra, Shiraz I.; Commiskey, Patricia; Ellison, Gary L.; DeShields, Mary

doi:10.1016/s0027-9684(15)31294-3

Cited by 166 publications

(180 citation statements)

References 41 publications

Supporting

Mentioning

159

Contrasting

Unclassified

Order By: Relevance

“…Metzeger et al showed that, from biological point of view, the age of 8 year-old dogs is equal to that of 48-51 years in humans (Metzger et al, 2005;Queiroga et al, 2011). Investigations have demonstrated that the peak incidence of CMGTs occurs in dogs aged approximately 7-10 years, which is equal to 44-56 years in humans and is roughly equal to the peak of HBC incidence (Jamal et al, 2007;Baquet et al, 2008). In terms of the involved anatomic region as well as the histopathological results, this study was in line with other similar studies (Karyannopoulo et al, 2005;Andrade et al, 2010).…”

Section: Discussionsupporting

confidence: 89%

Overexpression of HER-2/neu in Malignant Mammary Tumors: Translation of Clinicopathological Features from Dog to Human

Muhammadnejad¹,

Keyhani²,

Mortazavi³

et al. 2012

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 89%

Overexpression of HER-2/neu in Malignant Mammary Tumors: Translation of Clinicopathological Features from Dog to Human

Muhammadnejad¹,

Keyhani²,

Mortazavi³

et al. 2012

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

“…Ageadjusted mortality for blacks, although showing a declining trend, was nearly twice that of whites (7.79 vs 3.96, P < 0.05). Squamous cell carcinoma was more commonly diagnosed in blacks and white females, whereas adenocarcinoma was more common among white males (P < 0.001) [41] . The reasons are economic status, diet, and poor eating habits etc.…”

Section: Incidencementioning

confidence: 96%

Epidemiology of esophageal cancer

Zhang¹

2013

WJG

903

749

View full text Add to dashboard Cite

Esophageal cancer (EsC) is one of the least studied and deadliest cancers worldwide because of its extremely aggressive nature and poor survival rate. It ranks sixth among all cancers in mortality. In retrospective studies of EsC, smoking, hot tea drinking, red meat consumption, poor oral health, low intake of fresh fruit and vegetables, and low socioeconomic status have been associated with a higher risk of esophageal squamous cell carcinoma. Barrett's esophagus is clearly recognized as a risk factor for EsC, and dysplasia remains the only factor useful for identifying patients at increased risk, for the development of esophageal adenocarcinoma in clinical practice. Here, we investigated the epidemiologic patterns and causes of EsC. Using population based cancer data from the Surveillance, Epidemiology and End Results Program of the United States; we generated the most up-to-date stage distribution and 5-year relative survival by stage at diagnosis for 1998-2009. Special note should be given to the fact that esophageal cancer, mainly adenocarcinoma, is one of the very few cancers that is contributing to increasing death rates (20%) among males in the United States. To further explore the mechanism of development of EsC will hopefully decrease the incidence of EsC and improve outcomes.© 2013 Baishideng. All rights reserved.Key words: Risk factor; Barrett's esophagus; Cyclin D1 G870A; Esophageal neoplasm; Susceptibility; Polymorphism Core tip: Here, we investigated the epidemiologic patterns and causes of esophageal cancer. Using population based cancer data from the Surveillance, Epidemiology and End Results Program of the United States; we generated the most up-to-date stage distribution and 5-year relative survival by stage at diagnosis for

show abstract

“…Racial disparity also occurs between the 2 types of esophageal cancer. ESCC is more prevalent among Blacks, whereas EAC is at least twice as common in Whites as compared with other ethnic groups (7,8). Once diagnosed, Black patients showed poorer overall survival than Whites (9,10).…”

Section: Introductionmentioning

confidence: 95%

Early Diagnostic Biomarkers for Esophageal Adenocarcinoma—The Current State of Play

Shah

Saunders

Barbour

et al. 2013

Cancer Epidemiology, Biomarkers &Amp; Prevention

View full text Add to dashboard Cite

Esophageal adenocarcinoma (EAC) is one of the two most common types of esophageal cancer with alarming increase in incidence and very poor prognosis. Aiming to detect EAC early, currently high-risk patients are monitored using an endoscopic-biopsy approach. However, this approach is prone to sampling error and interobserver variability. Diagnostic tissue biomarkers related to genomic and cell-cycle abnormalities have shown promising results, although with current technology these tests are difficult to implement in the screening of high-risk patients for early neoplastic changes. Differential miRNA profiles and aberrant protein glycosylation in tissue samples have been reported to improve performance of existing tissue-based diagnostic biomarkers. In contrast to tissue biomarkers, circulating biomarkers are more amenable to population-screening strategies, due to the ease and low cost of testing. Studies have already shown altered circulating glycans and DNA methylation in BE/EAC, whereas disease-associated changes in circulating miRNA remain to be determined. Future research should focus on identification and validation of these circulating biomarkers in large-scale trials to develop in vitro diagnostic tools to screen population at risk for EAC development. Cancer Epidemiol Biomarkers Prev; 22(7); 1185-209. Ó2013 AACR.

show abstract

Breast Cancer Epidemiology in Blacks and Whites: Disparities in Incidence, Mortality, Survival Rates and Histology

Abstract: Background-This study presents black-white breast cancer statistics, tumor histology and receptor status, and treatment patterns for all ages and by age groups (under 40, between ages 40 and 49, and age 50 and over).

Cited by 166 publications

References 41 publications

Overexpression of HER-2/neu in Malignant Mammary Tumors: Translation of Clinicopathological Features from Dog to Human

Overexpression of HER-2/neu in Malignant Mammary Tumors: Translation of Clinicopathological Features from Dog to Human

Epidemiology of esophageal cancer

Early Diagnostic Biomarkers for Esophageal Adenocarcinoma—The Current State of Play

Contact Info

Product

Resources

About